Multimodal imaging to analyze the biomechanical properties of kidney tumors, evaluating feasibility, inter-modality correspondence, and diagnostic value (UroCCR-115).

Mattia Ronca^1,2, Paolo Conforti^1,2, Amandine Crombé^3,4, Manon Jaffredo^1,2, Solène Ricard^1,2, Thierry Colin⁵, Mokrane Yacoub⁶, Yann Le Bras³, Jean-Christophe Bernhard^1,2, Gaelle Margue^1,2, Eva Fourage-Jambon^2,3

¹Urology Department, Bordeaux University Hospital, Bordeaux, France.

²I, CaRe Bordeaux-BRIC Inserm U1312, Bordeaux, France.

³Service d'imagerie Médicale Adulte, Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

⁴Sarcotarget -BRIC Inserm U1312, Bordeaux, France.

⁵SOPHiA GENETICS, Multimodal R&D Team, Pessac, France.

⁶Department of Pathology, Bordeaux University Hospital, Bordeaux, France.

PubMed PMC DOI PDF

Abstract

INTRODUCTION: Assessment of renal tissue and renal tumor stiffness may provide complementary information for tissue characterization; however, conventional imaging modalities such as multiphasic computed tomography (CT) do not directly quantify biomechanical properties. Elastography techniques, including magnetic resonance elastography (MRE) and ultrasound elastography (US-E), allow noninvasive me…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.